Altimmune CFO Purchases $17,700 in Stock as Company Posts Steep Q4 Earnings Shortfall
Altimmune Chief Financial Officer Gregory L. Weaver bought 5,000 shares of company common stock on March 6, 2026, spending $17,700 at $3.54 per share. The purchase comes as the stock has slipped nearly 15% over the prior week and is trading nearer its 52-week low of $2.90 than its high of $7.73. Recent fourth-quarter 2025 results showed a wider-tha…